Cho WCS - Search Results

1

TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.

Wang YQ, Wu DH, Wei D, Shen JY, Huang ZW, Liang XY, Cho WCS, Ma J, Lv J, Chen YP. Wang YQ, et al. Among authors: cho wcs. Sci Adv. 2023 Jan 6;9(1):eadd0960. doi: 10.1126/sciadv.add0960. Epub 2023 Jan 6. Sci Adv. 2023. PMID: 36608137 Free PMC article.

2

MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.

Wang J, Du Y, Liu X, Cho WC, Yang Y. Wang J, et al. Biomed Res Int. 2015;2015:823620. doi: 10.1155/2015/823620. Epub 2015 May 6. Biomed Res Int. 2015. PMID: 26064956 Free PMC article. Review.

3

Immunotherapeutic approaches in nasopharyngeal carcinoma.

Chow JC, Ngan RK, Cheung KM, Cho WC. Chow JC, et al. Expert Opin Biol Ther. 2019 Nov;19(11):1165-1172. doi: 10.1080/14712598.2019.1650910. Epub 2019 Aug 13. Expert Opin Biol Ther. 2019. PMID: 31361154 Review.

4

Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.

To KKW, Fong W, Tong CWS, Wu M, Yan W, Cho WCS. To KKW, et al. Among authors: cho wcs. Expert Opin Drug Discov. 2020 Jan;15(1):63-83. doi: 10.1080/17460441.2020.1690449. Epub 2019 Nov 19. Expert Opin Drug Discov. 2020. PMID: 31739699 Review.

5

Cancer stem cell property and gene signature in bone-metastatic Breast Cancer cells.

Luo A, Xu Y, Li S, Bao J, Lü J, Ding N, Zhao Q, Fu Y, Liu F, Cho WC, Wei X, Wang H, Yu Z. Luo A, et al. Int J Biol Sci. 2020 Jul 19;16(14):2580-2594. doi: 10.7150/ijbs.45693. eCollection 2020. Int J Biol Sci. 2020. PMID: 32792858 Free PMC article.

6

Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse.

Cho WCS, Tse KP, Ngan RKC, Cheuk W, Ma VWS, Yang YT, Yip TTC, Tan KT, Chen SJ. Cho WCS, et al. Expert Rev Mol Diagn. 2020 Nov;20(11):1149-1159. doi: 10.1080/14737159.2020.1835473. Epub 2020 Nov 6. Expert Rev Mol Diagn. 2020. PMID: 33040630

7

MicroRNA Regulation of TRAIL in Renal Carcinoma: Tiny Juggernauts at Work.

Javed Z, Khan K, Sadia H, Raza S, Sharifi-Rad J, Cho WC. Javed Z, et al. Curr Mol Pharmacol. 2021 Oct 25;14(4):520-526. doi: 10.2174/1874467213999201124124649. Curr Mol Pharmacol. 2021. PMID: 33238861 Review.

8

An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).

Fu Q, Du Y, Yang C, Zhang D, Zhang N, Liu X, Cho WC, Yang Y. Fu Q, et al. Expert Opin Ther Targets. 2016 Jul;20(7):771-82. doi: 10.1080/14728222.2016.1181753. Epub 2016 May 11. Expert Opin Ther Targets. 2016. PMID: 27167185

9

Integrin α1 promotes tumorigenicity and progressive capacity of colorectal cancer.

Li H, Wang Y, Rong SK, Li L, Chen T, Fan YY, Wang YF, Yang CR, Yang C, Cho WC, Yang J. Li H, et al. Int J Biol Sci. 2020 Jan 16;16(5):815-826. doi: 10.7150/ijbs.37275. eCollection 2020. Int J Biol Sci. 2020. PMID: 32071551 Free PMC article.

10

Tumor mutational burden as a tissue-agnostic biomarker for cancer immunotherapy.

Sung WWY, Chow JCH, Cho WCS. Sung WWY, et al. Among authors: cho wcs. Expert Rev Clin Pharmacol. 2021 Feb;14(2):141-143. doi: 10.1080/17512433.2021.1865797. Epub 2020 Dec 23. Expert Rev Clin Pharmacol. 2021. PMID: 33322961 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

295 results

Search Page